Mar 25 |
Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why
|
Mar 23 |
Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections
|
Mar 22 |
Lyra Therapeutics files for $300M mixed shelf
|
Mar 22 |
Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High?
|
Mar 21 |
Lyra Therapeutics reports Q4 results
|
Mar 21 |
Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
|
Mar 8 |
Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going
|
Mar 1 |
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 1 |
Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
|
Feb 29 |
5 Small Drug Stocks to Buy From a Rebounding Industry
|